<DOC>
	<DOCNO>NCT02402244</DOCNO>
	<brief_summary>This research trial study Project : Every Child young patient cancer . Gathering health information time young patient cancer may help doctor find good method treatment on-going care .</brief_summary>
	<brief_title>Project : Every Child Younger Patients With Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To maintain Childhood Cancer Registry infant , child , adolescent , young adult cancer . II . To utilize clinical biological data help determine eligibility stratification , base childhood cancer disease classification schema , potential enrollment research subject onto Children 's Oncology Group ( COG ) therapeutic clinical trial . III . To develop well annotate childhood cancer biobank current future research collection biospecimens ( diagnosis , time progression , time recurrence and/or post-mortem ) , include tumor , host feasible parental germline deoxyribonucleic acid ( DNA ) ; key clinical data , include presentation , diagnostic , stag , summary treatment , outcome information , every child diagnose cancer COG institution . IV . To allow use registry data permission contact future consider participate non-therapeutic prevention research study involve child parent . OUTLINE : Patients undergo medical data review create Childhood Cancer Registry . Patients also undergo collection bio-specimen sample ( e.g. , tissue , blood , bone marrow , plasma , serum , buccal cell , saliva , cerebrospinal fluid , urine ) .</detailed_description>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<criteria>Enrollment occur time disease presentation include time disease progression recurrence ; patient enrol COG therapeutic study , enrollment APEC14B1 must occur prior enrollment onto therapeutic trial Patients know suspected neoplasm occur pediatric , adolescent young adult population eligible enrollment follow : All cancer case International Classification Diseases Oncology ( ICDO ) histologic behavior code two `` 2 '' ( carcinoma situ ) three `` 3 '' ( malignant ) All neoplastic lesion central nervous system regardless behavior , i.e. , benign , borderline malignant Other benign/borderline condition include : Mesoblastic nephroma Teratomas Myeloproliferative diseases include transient myeloproliferative disease Langerhan cell histiocytosis Lymphoproliferative diseases Subjects must = &lt; 25 year age time original diagnosis , except patient screen specifically eligibility onto COG ( COG participate National Clinical Trials Network ( NCTN ) ) therapeutic study , high upper age limit All patient parent legally authorize representative must sign write informed consent ; parent ask sign separate consent biospecimen submission</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>